Galmed Pharmaceuticals Has Received A Notice Of Allowance For A U.S. Patent Titled "TREATMENT FOR FIBROSIS AND INHIBITION OF FIBROSIS"

Benzinga Newsdesk www.benzinga.com Neutral 94.3%

Neg 0% Neu 94.3% Pos 0%

https://x.com/PatentGrants/status/2072409116040130916

https://patentcenter.uspto.gov/applications/17863472/ifw/docs

Comments

No comments yet. Be the first!